2-tert-butylhydroquinone has been researched along with Cognition Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Citron, BA; Hatic, H; Pick, CG; Rachmany, L; Rubovitch, V; Saykally, JN; Shaer, A | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Cognition Disorders
Article | Year |
---|---|
The nuclear factor erythroid 2-like 2 activator, tert-butylhydroquinone, improves cognitive performance in mice after mild traumatic brain injury.
Topics: Analysis of Variance; Animals; Antioxidants; Avoidance Learning; Brain; Brain Injuries; Caspase 3; Cell Line, Tumor; Cell Survival; Cognition Disorders; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; HSP70 Heat-Shock Proteins; Humans; Hydroquinones; Male; Maze Learning; Mice; Mice, Inbred ICR; Motor Activity; Neuroblastoma; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-jun; Purine Nucleosides; Recognition, Psychology; RNA, Messenger; Rotarod Performance Test; Time Factors | 2012 |